The National Institute for Pharmaceutical Research and Development has quietly been building momentum, and one of its most telling moves is the formation of a dedicated Ebola Response Team. It is the kind of structural decision that signals an institution getting serious about its role in public health emergencies, not just in theory but in practice.
Details from the source remain limited, but the establishment of this team points to a broader internal push under the current administration to strengthen research capacity, look after staff welfare, and position the institute as a frontline player in Nigeria's health security conversations.
What shape the rest of those gains are taking, and who is driving them, is a story worth watching closely.
Originally published by Premium Times.